Acknowledgements
Ovarian Cancer
ONCOLOGY, OVARIAN CANCER
The study was designed by academic researchers representing the North-Eastern German Society of Gynecological Oncology (NOGGO) Ovarian Cancer Study Group. We would like to thank all patients, their families, and carers who participated in this trial. We also thanks all investigators and their teams for their enthusiasm and constructive contribution; GSK, Germany, later acquired by Novartis oncology for funding the study. Project management, set-up, and hosting of the electronic data collection system, monitoring and data management were done by Alcedis. Emelina Sofia Fucaraccio provided medical writing assistance.